Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
First Western Financial
MYFW
$304M
| $352K | ﹤0.01% |
17,583
+9,309
| +113% | +$170K |
|
3877
Radware
RDWR
$1.1B
| $351K | ﹤0.01% |
15,743
+9,112
| +137% | +$188K |
|
3878
CALL
Lifestance Health
LFST
$4B
| $350K | ﹤0.01% |
50,000
| – | – |
|
3879
Entravision Communication
EVC
$1.03B
| $350K | ﹤0.01% |
169,068
+63,699
| +60% | +$127K |
|
3880
Citizens Financial Services
CZFS
$373M
| $348K | ﹤0.01% |
5,983
+4,434
| +286% | +$223K |
|
3881
Abeona Therapeutics
ABEO
$366M
| $348K | ﹤0.01% |
55,000
-21,394
| -28% | -$112K |
|
3882
Duluth Holdings
DLTH
$155M
| $347K | ﹤0.01% |
92,318
+46,527
| +102% | +$170K |
|
3883
DMC Global
BOOM
$138M
| $347K | ﹤0.01% |
26,741
+19,901
| +291% | +$252K |
|
3884
HighPeak Energy
HPK
$903M
| $346K | ﹤0.01% |
24,911
+19,333
| +347% | +$295K |
|
3885
BARK
BARK
$81.8M
| $345K | ﹤0.01% |
10,572
+6,287
| +147% | +$205K |
|
|
PSTX
3886
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $345K | ﹤0.01% |
120,464
+68,688
| +133% | +$213K |
|
3887
Aviat Networks
AVNW
$265M
| $345K | ﹤0.01% |
15,928
+11,926
| +298% | +$318K |
|
3888
Intrepid Potash
IPI
$456M
| $344K | ﹤0.01% |
14,350
+10,599
| +283% | +$252K |
|
3889
Sprott Copper Miners ETF
COPP
$262M
| $344K | ﹤0.01% |
13,250
| – | – |
|
|
NVRO
3890
DELISTED
NEVRO CORP.
NVRO
| $344K | ﹤0.01% |
61,496
-88,518
| -59% | -$619K |
|
3891
Superior Group of Companies
SGC
$185M
| $344K | ﹤0.01% |
22,181
+7,925
| +56% | +$129K |
|
3892
Mama's Creations
MAMA
$857M
| $344K | ﹤0.01% |
47,055
+12,213
| +35% | +$93.8K |
|
|
REFI
3893
Chicago Atlantic Real Estate Finance
REFI
$248M
| $343K | ﹤0.01% |
22,143
+16,189
| +272% | +$254K |
|
3894
Kyverna Therapeutics
KYTX
$444M
| $343K | ﹤0.01% |
70,167
+12,418
| +22% | +$95.7K |
|
|
TTSH
3895
DELISTED
Tile Shop Holdings
TTSH
| $343K | ﹤0.01% |
52,039
+28,608
| +122% | +$186K |
|
3896
Sun Life Financial
SLF
$46B
| $343K | ﹤0.01% |
5,907
+2,244
| +61% | +$117K |
|
3897
iShares Global Consumer Staples ETF
KXI
$1.07B
| $342K | ﹤0.01% |
5,200
| – | – |
|
3898
Amplify Energy
AMPY
$161M
| $341K | ﹤0.01% |
52,159
+38,151
| +272% | +$264K |
|
|
PYCR
3899
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $340K | ﹤0.01% |
23,991
+8,079
| +51% | +$107K |
|
3900
Black Diamond Therapeutics
BDTX
$96.8M
| $340K | ﹤0.01% |
78,151
+52,265
| +202% | +$284K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.